The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
BBA - REVIEWS ON CANCER
2020
1874
2
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res
2020
26
22
6051-6063
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med
2020
383
19
1827-1837
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
Gastroenterology
2020
159
5
1672-1685.e5
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2.
Gastroenterology
2020
159
5
1866-1881.e8
IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN MODERATE COVID-19 PATIENTS
Hepatology
2020
72 Suppl 1
88A-89A
IMPACT OF BASELINE ALANINE AMINOTRANSFERASE LEVELS ON THE SAFETY AND EFFICACY OF REMDESIVIR IN SEVERE COVID-19 PATIENTS
Hepatology
2020
72 Suppl 1
279A-279A
CHARACTERIZATION OF TREATMENT-INDUCED ADAPTIVE IMMUNE RESPONSES IN PANCREATIC DUCTAL ADENOCARCINOMA
J Immunother Cancer
2020
8 Suppl 2
A34-A34
Drug Resistance Spread in 6 Metropolitan Regions, Germany, 2001-20181.
Emerg Infect Dis
2020
26
10
2439-2443